TSE:4502Pharmaceuticals
Takeda Pharmaceutical (TSE:4502) Wins MIMRYLO Approval, Is The Stock Still Trading At A Discount?
Takeda Pharmaceutical (TSE:4502) is back in focus after two recent announcements. The stock is reacting to U.S. approval of MIMRYLO and an expanded AI collaboration with Weave Bio that targets global regulatory workflows.
Even after a 2.7% pullback in the latest session to ¥5,748, Takeda Pharmaceutical’s 30-day share price return of 9.1% and 90-day gain of 16.7% suggest momentum has been building. A 1-year total shareholder return of 30.8% points to sustained interest as new product approvals...